Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEAM Trial: Exemestane vs Tamoxifen in Early Breast Cancer
NCT00032136Phase 3Completed
- Sponsor
- CRUK & UCL Cancer Trials Centre
- Start
- Dec 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of exemestane in breast cancer, sponsored by CRUK & UCL Cancer Trials Centre. Started Dec 2001; status: completed.
02
Drugs
exemestane
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00032136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00032136.